Skip to main content
Clinical Trials/IRCT20210612051545N3
IRCT20210612051545N3
Recruiting
Phase 1

evaluation of human placenta extract effectiveness in the treatment of skin wrinkles: A phase I/II clinical trial

Tehran University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
skin wrinkles.
Sponsor
Tehran University of Medical Sciences
Enrollment
20
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Wrinkle lines on the face should be in the range of 3\-5 based on Wrinkle Severity Rating Scale

Exclusion Criteria

  • Suffering from uncontrolled chronic diseases including diabetes mellitus, underlying chronic liver, kidney and heart disease, chronic malnutrition, malignancy, coagulopathy or the use of anticoagulants, a history of autoimmune diseases and suffering from HBV, HIV, HCV viral infections
  • Any cosmetic procedure such as fat injection within a year and permanent filler, microneedling, RF, laser and other cases within the last 6 months, except for using cream.
  • Infection and any malignancy at the transplant recipient site
  • Failure to receive cells in the treatment area during the past year
  • Patients with vitiligo
  • Moderate to severe chronic skin diseases such as eczema and psoriasis
  • active acne
  • People who have had systemic retinoid treatment (within the last 6 months) or topical retinoid treatment (within the last 2 weeks
  • History of keloid
  • Women during pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials